![](https://endpts.com/wp-content/uploads/2023/03/Egletis-Therapeutics-CEO-Nicklas-Westerholm.jpg)
Nicklas Westerholm, Egetis Therapeutics CEO
Acquisition talks ongoing for Swedish rare disease biotech Egetis, shares up almost 40%
Shares of the Sweden-based rare disease biotech Egetis Therapeutics skyrocketed on Thursday afternoon as the company said it’s engaged in “ongoing discussion” with external parties …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.